Table 1: Demographics of the 43 subjects showing intraocular pressures and number of ocular hypotensive medications in use immediately prior to and at the 12-month interval after undergoing viscoelastic tube shunt flush. Subjects are listed in order of the magnitude of intraocular pressure reduction attained

Age		Gepder		Postshut		Gliucoma etiology		Eye		Preop IOP		12-month IOP		IOP change		Preop meds		12-month meds
54		M		1		Traumatic		L		56		9		–47		0		0
47		M		4		Neovascular		R		40		16		–24		5		0
81		F		8		Uveitic		R		38		15		–23		3		3
41		F		16		Uveitic		R		28		7		–21		1		0
41		F		2		Uveitic		R		34		13		–21		0		0
71		F		8		Uveitic		R		33		14		–19		0		0
50		F		3		Congenital		L		39		10		–19		0		0
62		M		54		Neovascular		L		27		9		–18		0		0
87		M		1		POAG		R		36		19		–17		0		0
57		M		3		Neovascular		L		32		15		–17		0		0
78		F		15		Uveitic		L		32		15		–17		0		0
78		F		2		CACG		R		34		18		–16		0		0
75		M		8		Uveitic		L		30		14		–16		0		0
80		F		55		CACG		R		27		12		–15		1		0
1		M		7		Congenital		R		24		12		–12		0		0
49		F		1		POAG		L		34		22		–12		0		0
75		M		8		Uveitic		L		25		14		–11		0		0
14		M		9		Congenital		L		23		14		–9		1		0
54		F		19		POAG		L		24		15		–9		0		0
43		M		111		Congenital		L		21		12		–9		0		0
62		F		154		Neovascular		R		24		15		–9		1		1
1		M		1		Congenital		R		23		15		–8		0		0
53		M		1		Uveitic		L		30		22		–8		0		0
79		F		4		Uveitic		L		29		22		–7		0		0
83		F		21		POAG		L		28		21		–7		3		2
22		F		3		Congenital		L		26		20		–6		2		2
10		F		11		Congenital		L		24		18		–6		1		1
4		M		60		Traumatic		L		19		15		–4		0		0
56		F		31		POAG		L		19		16		–3		0		0
76		M		5		NAG		R		16		13		–3		0		0
4		M		21		Congenital		R		23		20		–3		0		0
72		F		4		Uveitic		R		21		18		–3		0		0
5		M		42		Congenital		R		18		16		–2		2		2
6		M		38		Congenital		L		19		17		–2		2		0
42		F		2		Neovascular		L		28		26		–2		0		0
9		M		95		Congenital		L		23		21		–2		3		4
77		F		136		ACG		L		16		15		–1		0		0
7		M		7		Congenital		R		20		22		2		0		0
54		F		51		Uveitic		L		19		21		2		1		2
76		M		9		Uveitic		L		28		33		5		0		0
87		F		38		Uveitic		L		28		33		5		0		0
3		M		31		Congenital		R		25		33		8		0		0
97		R		2		Traumatic		L		21		29		8		3		3

M: Male; F: Female